Academic Journal
Q1European Journal of Internal Medicine
About European Journal of Internal Medicine
About European Journal of Internal Medicine
European Journal of Internal Medicine is a peer-reviewed scholarly journal published by Elsevier B.V. (Netherlands). It focuses on Q1. Publication coverage spans 1989-2026.
Key indicators: ISSN 0953-6205, 1879-0828; H-index 105.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (105): Exceptionally high — 105 articles have each been cited at least 105 times. This indicates deep, sustained influence in the field.
Publishing in European Journal of Internal Medicine
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of European Journal of Internal Medicine?
0953-6205, 1879-0828.
Who publishes European Journal of Internal Medicine?
Elsevier B.V..
What are European Journal of Internal Medicine's metrics?
H-index 105.
Where do I submit to European Journal of Internal Medicine?
Via the official website.
Is European Journal of Internal Medicine peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Atrial Fibrillation Management and Outcomes; Venous Thromboembolism Diagnosis and Management; Heart Failure Treatment and Management; Liver Disease Diagnosis and Treatment; Sepsis Diagnosis and Treatment; Cardiovascular Function and Risk Factors.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,520.00 USD; 3,290.00 EUR; 2,820.00 GBP; 436,590.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Chronic hyperkeratotic and pustular cutaneous lesions of the hand
Claude Bachmeyer, Philippe Moguelet, Jean-Benoit Monfort
2026-10 · DOI: 10.1016/j.ejim.2026.107021Beyond survival: nuances in the robustness of SGLT2 inhibitor evidence for HFpEF
Qi Sun, Longqing Yu
2026-10 · DOI: 10.1016/j.ejim.2026.106892Discharge medical treatment implementation and predictors of a successful decongestion in patients with acute heart failure: first data from the BRING-UP 3 Heart Failure Study
Fabrizio Oliva, Francesco Orso, Christian Basile, Furio Colivicchi et al.
2026-10 · DOI: 10.1016/j.ejim.2026.106860From biological discovery to clinical translation: depot-specific adipose tissue miRNA profiling in gastrointestinal cancer
Federica Tambaro, Giovanni Imbimbo, Alessio Molfino
2026-10 · DOI: 10.1016/j.ejim.2026.107112Epicardial fat enhances prediction of exercise-induced hypertension and ventricular arrhythmias in asymptomatic normotensive individuals
Klara Komici, Giuseppe Rengo, Grazia Daniela Femminella, Raffaela Pagliaro et al.
2026-10 · DOI: 10.1016/j.ejim.2026.106963Implementation of guideline-directed cardioprotective therapy in patients living with type 2 diabetes in outpatient cardiology ambulatory setting: the Italian CardioMET registry
Paola Gargiulo, Federica Marzano, Laura Liccardi, Savina Nodari et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107183Carbapenem-resistant Acinetobacter baumannii pneumonia: Treatment challenges
Demosthenes Makris, Jordi Rello
2026-10 · DOI: 10.1016/j.ejim.2026.107136Development and external validation of an international score to predict cancer 1 year after venous thromboembolism
Luis Jara-Palomares, Behnood Bikdeli, David Jiménez, Alfonso Muriel et al.
2026-10 · DOI: 10.1016/j.ejim.2026.106891Linking the exposome to frailty: pathways, mechanisms, clinical implications, and prevention
Mustafa Guldan, Ermeena Shah, Rama Al-Shiab, Lasin Ozbek et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107006Identification and management of sarcopenia in patients with multimorbidity: An EFIM critically appraised and adapted guideline
M. Bernabeu-Wittel, I. Marín-León, C. Angermann, P. Cubo-Romano et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107121Early C-reactive protein change and mortality in emergency admissions: a trajectory, not a target
Satoshi Kutsuna, Shungo Yamamoto, Ryuichi Minoda Sada
2026-10 · DOI: 10.1016/j.ejim.2026.107226Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study
Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Ilona Kowalik et al.
2026-10 · DOI: 10.1016/j.ejim.2026.106920Serological and clinical features in patients with anti‐centromere antibody positivity
Taro Horino
2026-10 · DOI: 10.1016/j.ejim.2026.106908Reconsidering the interpretation of prescribing shifts and treatment response in the AMBI-RA study. Authors’ reply
Riccardo Bertola, Carlo Garaffoni, Beatrice Maranini, Alessandra Bortoluzzi et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107162Subclinical atrial fibrillation in patients treated with Bruton’s tyrosine kinase inhibitors: ‘Much ado about nothing or phantom menace’
Andrés J. Muñoz Martín, Eduardo Zatarain-Nicolás, Sara Pérez Ramírez
2026-10 · DOI: 10.1016/j.ejim.2026.107125Healthcare sustainability and the planetary crisis: A solution orientation
Elizabeth Cerceo
2026-10 · DOI: 10.1016/j.ejim.2026.106993Twelve-year trends in sex and age of patients with COPD and chronic respiratory failure undergoing pulmonary rehabilitation
Matteo Vigna, Gaia Riboni, Valentina Tibollo, Riccardo Bellazzi et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107035Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis
Eirini I. Rigopoulou, Vasiliki Lygoura, Konstantinos Papantoniou, Stella Gabeta et al.
2026-10 · DOI: 10.1016/j.ejim.2026.107219Breaking LDL-cholesterol inertia after myocardial infarction: from discharge prescription to closed-loop care
Pierre-Guillaume Piriou, Philippe Gabriel Steg
2026-10 · DOI: 10.1016/j.ejim.2026.107157Interpreting the neutrophil-to-lymphocyte ratio in stable chronic obstructive pulmonary disease: severity, case mix, and clinical utility. Author's reply
Marco Vanetti, Antonio Spanevello
2026-10 · DOI: 10.1016/j.ejim.2026.107236Reviews
Community Reviews
Version History
October 9, 2026 at 7:08 pm
September 25, 2026